Higher cerebrospinal fluid to plasma ratio of p-cresol sulfate and indoxyl sulfate in patients with Parkinson’s disease

Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis

Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386

A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation

Erel, Ö. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2003.11.015 · Cited by 2,940

Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk

Zhu, W., Gregory, J. C., Org, E., Buffa, J. A., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.011 · Cited by 1,968

Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections

Nau, R., Sörgel, F., & Eiffert, H. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00007-10 · Cited by 1,063

Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease

Hughes, A. J., Daniel, S. E., & Lees, A. J. (2001) · Neurology · doi:10.1212/wnl.57.8.1497 · Cited by 807

Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis

Ma, Q., Xing, C., Long, W., Wang, H. Y., Liu, Q., & Wang, R. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1434-3 · Cited by 767

Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target

Janeiro, M., Ramírez, M., Milagro, F., Martínez, J., & Solas, M. (2018) · Nutrients · doi:10.3390/nu10101398 · Cited by 631

Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS

Kemna, E., Pickkers, P., Nemeth, E., van der Hoeven, H., & Swinkels, D. (2005) · Blood · doi:10.1182/blood-2005-03-1159 · Cited by 498

Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women

Wang, Z., Bergeron, N., Levison, B. S., Li, X. S., Chiu, S., Jia, X., Koeth, R. A., Li, L., Wu, Y., Tang, W. H. W., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy799 · Cited by 496

p-Cresyl Sulfate

Gryp, T., Vanholder, R. C., Vaneechoutte, M., & Glorieux, G. (2017) · Toxins · doi:10.3390/toxins9020052 · Cited by 427

Age-associated Physiological and Pathological Changes at the Blood-Brain Barrier: A Review

Erdő, F., Denes, L., & de Lange, E. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16679420 · Cited by 426

Striatal Blood–Brain Barrier Permeability in Parkinson'S Disease

Gray, M. T., & Woulfe, J. M. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.32 · Cited by 409

Trimethylamine‐ N ‐oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: A randomized controlled trial

Cho, C. E., Taesuwan, S., Malysheva, O. V., Bender, E., Tulchinsky, N. F., Yan, J., Sutter, J. L., & Caudill, M. A. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600324 · Cited by 405

p -Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase

Watanabe, H., Miyamoto, Y., Honda, D., Tanaka, H., Wu, Q., Endo, M., Noguchi, T., Kadowaki, D., Ishima, Y., Kotani, S., et al. (2013) · Kidney International · doi:10.1038/ki.2012.448 · Cited by 391

Damage to dopaminergic neurons by oxidative stress in Parkinson's disease (Review)

Guo, J., Zhao, X., Li, Y., Li, G., & Liu, X. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3406 · Cited by 353

Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)

Tain, Y., & Hsu, C. (2017) · Toxins · doi:10.3390/toxins9030092 · Cited by 264

Effect of egg ingestion on trimethylamine-N-oxide production in humans: a randomized, controlled, dose-response study , , ,

Miller, C. A., Corbin, K. D., da Costa, K.-A., Zhang, S., Zhao, X., Galanko, J. A., Blevins, T., Bennett, B. J., O’Connor, A., & Zeisel, S. H. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.087692 · Cited by 240

The production of p-cresol sulfate and indoxyl sulfate in vegetarians versus omnivores

Patel, K. P., Luo, F. J.-G., Plummer, N. S., Hostetter, T. H., & Meyer, T. W. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12491211 · Cited by 226

Role of blood–brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain

Ohtsuki, S., Asaba, H., Takanaga, H., Deguchi, T., Hosoya, K., Otagiri, M., & Terasaki, T. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01108.x · Cited by 216

Indoxyl Sulfate Is a Nephro-Vascular Toxin

Niwa, T. (2010) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2010.05.002 · Cited by 207

Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120

Liu, W.-C., Tomino, Y., & Lu, K. (2018) · Toxins · doi:10.3390/toxins10090367 · Cited by 200

Indoxyl Sulfate Affects Glial Function Increasing Oxidative Stress and Neuroinflammation in Chronic Kidney Disease: Interaction between Astrocytes and Microglia

Adesso, S., Magnus, T., Cuzzocrea, S., Campolo, M., Rissiek, B., Paciello, O., Autore, G., Pinto, A., & Marzocco, S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00370 · Cited by 184

NF-κB plays an important role in indoxyl sulfate-induced cellular senescence, fibrotic gene expression, and inhibition of proliferation in proximal tubular cells

Shimizu, H., Bolati, D., Adijiang, A., Muteliefu, G., Enomoto, A., Nishijima, F., Dateki, M., & Niwa, T. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00471.2010 · Cited by 178

Blood−brain barrier transporters and response to CNS-active drugs

Urquhart, B. L., & Kim, R. B. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0714-8 · Cited by 175

The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid

Del Rio, D., Zimetti, F., Caffarra, P., Tassotti, M., Bernini, F., Brighenti, F., Zini, A., & Zanotti, I. (2017) · Nutrients · doi:10.3390/nu9101053 · Cited by 172

TMAO is Associated with Mortality: Impact of Modestly Impaired Renal Function

Gruppen, E. G., Garcia, E., Connelly, M. A., Jeyarajah, E. J., Otvos, J. D., Bakker, S. J. L., & Dullaart, R. P. F. (2017) · Scientific Reports · doi:10.1038/s41598-017-13739-9 · Cited by 146

Parkinson disease with constipation: clinical features and relevant factors

Yu, Q.-J., Yu, S., Zuo, L.-J., Lian, T., Hu, Y., Wang, R., Piao, Y., Guo, P. F., Liu, L., Jin, Z. Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-16790-8 · Cited by 146

Cerebro-renal interactions: Impact of uremic toxins on cognitive function

Watanabe, K., Watanabe, T., & Nakayama, M. (2014) · NeuroToxicology · doi:10.1016/j.neuro.2014.06.014 · Cited by 145

Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis

Noga, M. J., Dane, A. D., Shi, S., Attali, A., van Aken, H. H. M., Suidgeest, E., Tuinstra, T., Muilwijk, B., Coulier, L., Luider, T. M., et al. (2011) · Metabolomics · doi:10.1007/s11306-011-0306-3 · Cited by 138

Protein-Bound Uremic Toxins: New Insight from Clinical Studies

Liabeuf, S., Drüeke, T. B., & Massy, Z. A. (2011) · Toxins · doi:10.3390/toxins3070911 · Cited by 137

Trimethylamine N-Oxide, Circulating Endothelial Progenitor Cells, and Endothelial Function in Patients with Stable Angina

Chou, R., Chen, C., Chen, I., Huang, H.-L., Lu, Y., Kuo, C., Chang, C., Huang, P., Chen, J., & Lin, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-40638-y · Cited by 135

The Impact of Uremic Toxins on Cerebrovascular and Cognitive Disorders

Assem, M., Lando, M., Grissi, M., Kamel, S., Massy, Z. A., Chillon, J., & Hénaut, L. (2018) · Toxins · doi:10.3390/toxins10070303 · Cited by 122

Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry

Kikuchi, K., Itoh, Y., Tateoka, R., Ezawa, A., Murakami, K., & Niwa, T. (2010) · Journal of Chromatography B · doi:10.1016/j.jchromb.2010.09.006 · Cited by 121

Associations of current diet with plasma and urine TMAO in the KarMeN study: direct and indirect contributions

Krüger, R., Merz, B., Rist, M. J., Ferrario, P. G., Bub, A., Kulling, S. E., & Watzl, B. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700363 · Cited by 114

Increased Urinary Indoxyl Sulfate (Indican): New Insights into Gut Dysbiosis in Parkinson’s Disease

Cassani, E., Barichella, M., Cancello, R., Cavanna, F., Iorio, L., Cereda, E., Bolliri, C., Zampella Maria, P., Bianchi, F., Cestaro, B., et al. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.02.004 · Cited by 108

Pathogenic Mechanisms of Neurodegeneration in Parkinson Disease

Mullin, S., & Schapira, A. H. V. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2014.09.010 · Cited by 108

Altered Gut Microbiome and Intestinal Pathology in Parkinson’s Disease

Chiang, H., & Lin, C. (2019) · Journal of Movement Disorders · doi:10.14802/jmd.18067 · Cited by 107

Hepcidin, an emerging and important player in brain iron homeostasis

Vela, D. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1399-5 · Cited by 106

The nature, consequences, and management of neurological disorders in chronic kidney disease

Jabbari, B., & Vaziri, N. D. (2017) · Hemodialysis International · doi:10.1111/hdi.12587 · Cited by 104

Expression of Iron Transporters and Pathological Hallmarks of Parkinson’s and Alzheimer’s Diseases in the Brain of Young, Adult, and Aged Rats

Lü, L., Qian, Z., Wu, K.-C., Yung, W., & Ke, Y. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0067-0 · Cited by 92

Serum prohepcidin concentration: no association with iron absorption in healthy men; and no relationship with iron status in men carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women

Roe, M. A., Spinks, C. A., Heath, A. M., Harvey, L. J., Foxall, R., Wimperis, J. Z., Wolf, C., & Fairweather‐Tait, S. J. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507336829 · Cited by 89

Mood effects of the amino acids tryptophan and tyrosine

Parker, G. B., & Brotchie, H. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01706.x · Cited by 86

Differential urinary metabolites related with the severity of major depressive disorder

Chen, J., Zhou, C., Zheng, P., Cheng, K., Wang, H., Li, J., Zeng, L., & Xie, P. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.06.012 · Cited by 86

Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis

Fang, X. (2015) · International Journal of Neuroscience · doi:10.3109/00207454.2015.1096271 · Cited by 84

The uremic toxin indoxyl sulfate interferes with iron metabolism by regulating hepcidin in chronic kidney disease

Hamano, H., Ikeda, Y., Watanabe, H., Horinouchi, Y., Izawa‐Ishizawa, Y., Imanishi, M., Zamami, Y., Takechi, K., Miyamoto, L., Ishizawa, K., et al. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx252 · Cited by 63

Trimethylamine N-Oxide From Gut Microbiota in Chronic Kidney Disease Patients: Focus on Diet

Moraes, C., Fouque, D. P., Amaral, A. C. F., & Mafra, D. (2015) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2015.06.004 · Cited by 57

Asymmetric dimethylarginine exacerbates Aβ-induced toxicity and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease

Luo, Y., Yue, W., Quan, X., Wang, Y., Zhao, B., & Lu, Z. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.12.002 · Cited by 55

Asymmetrical Dimethylarginine Is Increased in Plasma and Decreased in Cerebrospinal Fluid of Patients with Alzheimer’s Disease

Arlt, S., Schulze, F., Eichenlaub, M., Maas, R., Lehmbeck, J. T., Schwedhelm, E., Jahn, H., & Böger, R. H. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000144026 · Cited by 53

Bowel Habits and the Association With Uremic Toxins in Non–Dialysis-Dependent Chronic Kidney Disease Patients

Ramos, C. I., Armani, R. G., Canziani, M. E. F., Dolenga, C. J. R., Nakao, L. S., Campbell, K. L., & Cuppari, L. (2019) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2019.02.004 · Cited by 53

Pesticides, polychlorinated biphenyls and polycyclic aromatic hydrocarbons in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a case-control study

Vinceti, M., Violi, F., Tzatzarakis, M. N., Mandrioli, J., Malagoli, C., Hatch, E. E., Fini, N., Fasano, A., Rakitskii, V. N., Kalantzi, O., et al. (2017) · Environmental Research · doi:10.1016/j.envres.2017.02.025 · Cited by 51

Serum hepcidin but not prohepcidin may be an effective marker for anemia of inflammation (AI)

Sasu, B. J., Li, H., Rose, M. J., Arvedson, T. L., Doellgast, G., & Molineux, G. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.07.013 · Cited by 43

Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l ‐ DOPA treatment and changes in levodopa‐induced dyskinesia

Andersen, A. D., Blaabjerg, M., Binzer, M., Kamal, A., Thagesen, H., Kjær, T. W., Stenager, E., & Gramsbergen, J. B. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13997 · Cited by 43

Dimethylarginines, Homocysteine Metabolism, and Cerebrospinal Fluid Markers for Alzheimer's Disease

Arlt, S., Schwedhelm, E., Kölsch, H., Jahn, H., Linnebank, M., Smulders, Y. M., Jessen, F., Böger, R. H., & Popp, J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-112138 · Cited by 39

Indoxyl 3-sulfate stimulates Th17 differentiation enhancing phosphorylation of c-Src and STAT3 to worsen experimental autoimmune encephalomyelitis

Hwang, S., Hwang, Y.-J., Yun, M.-O., Kim, J.-H., Oh, G.-S., & Park, J. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.04.016 · Cited by 38

Serum and cerebrospinal fluid concentrations of homoarginine, arginine, asymmetric and symmetric dimethylarginine, nitrite and nitrate in patients with multiple sclerosis and neuromyelitis optica

Haghikia, A., Kayacelebi, A. A., Beckmann, B., Hanff, E., Gold, R., Haghikia, A., & Tsikas, D. (2015) · Amino Acids · doi:10.1007/s00726-015-2015-0 · Cited by 36

Increased risks of parkinsonism in the 3 years after chronic renal failure

Lin, H., Lin, H.-C., & Chen, Y.-H. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02896.x · Cited by 33

Brain Atrophy and Cognitive Impairment in Chronic Kidney Disease

Tsuruya, K., & Yoshida, H. (2018) · Contributions to nephrology · doi:10.1159/000485694 · Cited by 31

Nitric Oxide Dysregulation in Patients With Heart Failure

Mommersteeg, P. M. C., Schoemaker, R. G., Eisel, U. L. M., Garrelds, I. M., Schalkwijk, C. G., & Kop, W. J. (2015) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000162 · Cited by 30

Motor fluctuations and dyskinesias in advanced/end stage Parkinson’s disease: a study from a population of brain donors

Papapetropoulos, S., & Mash, D. C. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0603-6 · Cited by 20

Correlation of the L-Arginine Pathway with Thrombo-Inflammation May Contribute to the Outcome of Acute Ischemic Stroke

Molnár, T., Pusch, G., Nagy, L., Kéki, S., Berki, T., & Illés, Z. (2016) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2016.05.018 · Cited by 20

Higher serum levels of pro-hepcidin in patients with Parkinson’s disease treated with deep brain stimulation

Kwiatek-Majkusiak, J., Geremek, M., Koziorowski, D., Tomasiuk, R., Szlufik, S., & Friedman, A. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.06.031 · Cited by 19

High asymmetric dimethylarginine, symmetric dimethylarginine and L-arginine levels in migraine patients

Reyhani, A., Çelik, Y., Karadağ, Ç. H., Gündüz, Ö., Asıl, T., & Süt, N. (2017) · Neurological Sciences · doi:10.1007/s10072-017-2970-1 · Cited by 18

Permeability of blood–brain barrier in macaque model of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced Parkinson disease

Thiollier, T., Wu, C., Contamin, H., Li, Q., Zhang, J., & Bézard, E. (2016) · Synapse · doi:10.1002/syn.21889 · Cited by 13

Reversible parkinsonism with lentiform fork sign as an initial and dominant manifestation of uremic encephalopathy

Park, J., Kim, S.-U., Choi, J., Jung, J., Kwon, D., & Park, M. H. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.08.002 · Cited by 7

Evaluation of serum hepcidin concentrations in Parkinson’s disease patients

Manolov, V., Hadjidekova, S. P., Petrova, J., Vasilev, V., Petrova, M., Kunchev, T., Jelev, Y., Jeliazkov, P., Gramatikova, Z., Voleva, S., et al. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.11.257 · Cited by 1

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases

Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193

A gut-derived metabolite alters brain activity and anxiety behaviour in mice

Needham, B. D., Funabashi, M., Adame, M. D., Wang, Z., Boktor, J. C., Haney, J., Wu, W.-L., Rabut, C., Ladinsky, M. S., Hwang, S.-J., et al. (2022) · Nature · doi:10.1038/s41586-022-04396-8 · Cited by 489

Microbiota-derived metabolites as drivers of gut–brain communication

Ahmed, H., Leyrolle, Q., Koistinen, V., Kärkkäinen, O., Layé, S., Delzenne, N., & Hanhineva, K. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2102878 · Cited by 462

The microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic

Tan, A. H., Lim, S. Y., & Lang, A. E. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00681-2 · Cited by 392

Comprehensive metabolic profiling of Parkinson’s disease by liquid chromatography-mass spectrometry

Shao, Y., Li, T., Liu, Z., Wang, X., Xu, X., Li, S., Xu, G., & Le, W. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00425-8 · Cited by 226

Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease

Jiménez-Jiménez, F. J., Alonso‐Navarro, H., García‐Martín, E., & Agúndez, J. A. G. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00369 · Cited by 85

NITRITE AND MALONDIALDEHYDE CONTENT IN CEREBROSPINAL FLUID OF PATIENTS WITH PARKINSON’S DISEASE

Shukla, R., RAJANI, M., SRIVASTAVA, N., Barthwal, M. K., & Dikshit, M. (2006) · International Journal of Neuroscience · doi:10.1080/00207450500513989 · Cited by 40

Oxysterols and Parkinson's disease: Evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease

Björkhem, I., Lövgren‐Sandblom, A., Leoni, V., Meaney, S., Brodin, L., Salveson, L., Winge, K., Pålhagen, S., & Svenningsson, P. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.09.003 · Cited by 112

Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's Disease

Heilman, P. L., Wang, E. W., Lewis, M. M., Krzyżanowski, S., Capan, C. D., Burmeister, A. R., Du, G., Galvis, M. L. E., Brundin, P., Huang, X., et al. (2020) · Movement Disorders · doi:10.1002/mds.28202 · Cited by 134

Cerebrospinal fluid levels of oxidative stress measured using diacron-reactive oxygen metabolites and biological antioxidant potential in patients with Parkinson’s disease and progressive supranuclear palsy

Takahashi, K., Iwaoka, K., Takahashi, K., Suzuki, Y., Taguchi, K., Yamahara, K., & Maeda, T. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135975 · Cited by 12